Articles From: Medicine Chest Pharmacy Selects Innovatix as Its Exclusive Group Purchasing Organization to Medifast Adds Blueberry Muffin Soft Bake to Product Line


2014/3/26
Innovatix, the nation’s largest non-acute care group purchasing organization (GPO) is pleased to welcome Medicine Chest Pharmacy (Sulphur Springs, Texas) to its long-term care pharmacy membership.
Sign-up for Medicine Chest Pharmacy Selects Innovatix as Its Exclusive Group Purchasing Organization investment picks
2013/7/18
SAN DIEGO, July 18, 2013 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the funding and regulatory approvals of a NIH-based grant for a Phase 2b trial of MN-166 (ibudilast) in subjects with progressive multiple sclerosis (progressive MS). The principal investigator will be Robert Fox, M.D., M.S., FAAN, Staff Neurologist at the Mellen Center for Multiple Sclerosis at Cleveland Clinic.
Sign-up for MediciNova Announces Initiation of a Cooperative Phase 2b Trial of MN-166 in Progressive Multiple Sclerosis investment picks
2014/4/8
SAN DIEGO, April 8, 2014 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the appointment of Esther van den Boom as Chief Financial Officer.
Sign-up for MediciNova Announces Management Appointment investment picks
SAN DIEGO, Oct.
Sign-up for MediciNova Appoints Geoffrey O'Brien as Vice President investment picks
2014/4/8
SAN DIEGO, April 8, 2014 (GLOBE NEWSWIRE) -- MediciNova, Inc. a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the appointment of Mr.
Sign-up for MediciNova Appoints Yoshio Ishizaka to its Board of Directors investment picks
SAN DIEGO, Oct.
Sign-up for MediciNova Appoints Yutaka Kobayashi to Its Board of Directors investment picks
2013/11/11
SAN DIEGO, Nov.
Sign-up for MediciNova Receives New Patent Covering MN-221 in Irritable Bowel Syndrome investment picks
SAN DIEGO, Aug.
Sign-up for MediciNova Reports Second Quarter 2013 Results investment picks
SAN DIEGO, Nov.
Sign-up for MediciNova Reports Third Quarter 2013 Results investment picks
2013/9/6
Medidata Solutions (NASDAQ:MDSO) , the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Tarek Sherif, chairman and chief executive officer, and Cory Douglas, chief financial officer, will participate in two upcoming investor conferences in September.
Sign-up for Medidata Executives Participate in Upcoming Investor Conferences investment picks
Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, provided an update on its long-term financial model.
Sign-up for Medidata Raises Long-Term Revenue Growth Target to 20-25% investment picks
2014/2/6
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced its financial results for the fourth quarter and full year 2013, and provided detailed financial guidance for the full year 2014.
Sign-up for Medidata Reports Record Full Year and Fourth Quarter 2013 Results investment picks
2014/4/9
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its first quarter 2014 financial results before the open of the market on Tuesday, April 22, 2014.
Sign-up for Medidata Schedules First Quarter Earnings Conference Call for April 22, 2014 investment picks
2014/1/24
Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its fourth quarter 2013 financial results before the open of the market on Thursday, February 6, 2014.
Sign-up for Medidata Schedules Fourth Quarter Earnings Conference Call for February 6, 2014 investment picks
2013/8/8
Medidata Solutions, Inc. (NASDAQ: MDSO) today announced that the initial purchasers for the previously announced private placement of $250 million aggregate principal amount of Medidata’s 1.00% Convertible Senior Notes due 2018 (the “Notes”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Act”), have elected to fully exercise their overallotment option to purchase an additional $37.5 million aggregate principal amount of the Notes.
Sign-up for Medidata Solutions Announces Exercise in Full of Overallotment Option for 1.00% Convertible Senior Notes Due 2018 investment picks
2013/8/7
Medidata Solutions, Inc. (NASDAQ: MDSO) today announced the pricing of an offering of $250 million aggregate principal amount of its 1.00% convertible senior notes due 2018 (the “Notes”). The Notes are being offered in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Act”). Medidata has granted the initial purchasers a 30-day option to purchase up to an additional $37.5 million aggregate principal amount of the Notes on the same terms and conditions to cover over-allotments, if any.
Sign-up for Medidata Solutions Announces Pricing of Convertible Senior Notes Offering investment picks
2013/8/5
Medidata Solutions, Inc. (NASDAQ: MDSO) today announced its intention to offer, subject to market conditions and other factors, $200 million aggregate principal amount of convertible senior notes due 2018 (the “Notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Act”). Medidata also expects to grant the initial purchasers of the Notes a 30-day option to purchase up to an additional $30 million aggregate principal amount of the Notes to cover over-allotments.
Sign-up for Medidata Solutions Announces Proposed $200 Million Offering of Convertible Senior Notes Due 2018 investment picks
Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its Board of Directors approved a two-for-one (2:1) split of the Company's common stock at a regularly scheduled board meeting on November 7, 2013.
Sign-up for Medidata Solutions Announces Two-for-One Stock Split investment picks
Medidata Solutions (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced its financial results for the third quarter 2013 and provided detailed financial guidance.
Sign-up for Medidata Solutions Reports Record Third Quarter 2013 Results investment picks
2013/10/10
Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its third quarter 2013 financial results before the open of the market on Thursday, October 24, 2013.
Sign-up for Medidata Solutions Schedules Third Quarter Earnings Conference Call for October 24, 2013 investment picks
Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will host a financial analyst day on Thursday, November 21, 2013 in New York City.
Sign-up for Medidata Solutions to Host Financial Analyst Day in New York City on November 21 investment picks
Medidata Solutions (NASDAQ:MDSO) , the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Tarek Sherif, chairman and chief executive officer, and Cory Douglas, chief financial officer, will present at the Citi Global Technology Conference on Tuesday, September 3, 2013 at 12:50 p.m. ET in New York.
Sign-up for Medidata Solutions to Present at Citi Global Technology Conference investment picks
2014/2/25
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Tarek Sherif, chief executive officer, and Cory Douglas, chief financial officer, will present at the Morgan Stanley Technology, Media & Telecom Conference on March 3, 2014, at 3:25 p.m. PT (6:25 p.m. ET) in San Francisco.
Sign-up for Medidata to Present at Morgan Stanley Technology, Media & Telecom Conference investment picks
2014/3/5
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Tarek Sherif, chief executive officer, and Cory Douglas, chief financial officer, will present at the Piper Jaffray Technology, Media & Telecommunications Conference on March 12, 2014, at 2:00 p.m. ET in New York.
Sign-up for Medidata to Present at Piper Jaffray Technology, Media & Telecommunications Conference investment picks
Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Glen de Vries, president, and Cory Douglas, chief financial officer, will present at the 16 th Annual Needham Growth Conference on January 15, 2014, at 12:05 p.m. ET in New York City.
Sign-up for Medidata to Present at the 16th Annual Needham Growth Conference investment picks
Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Cory Douglas, chief financial officer, will present at the Credit Suisse 2013 Technology Conference on Thursday, December 5, 2013, at 10:00 a.m. MT (12:00 p.m. ET) in Scottsdale, AZ.
Sign-up for Medidata to Present at the Credit Suisse 2013 Technology Conference investment picks
EFFINGHAM, Ga.
Sign-up for Medient Secures $5,000,000 Line Of Credit For Development, P&A investment picks
OWINGS MILLS, Md.
Sign-up for Medifast Adds Blueberry Muffin Soft Bake to Product Line investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Medicine Chest Pharmacy Selects Innovatix as Its Exclusive Group Purchasing Organization to Medifast Adds Blueberry Muffin Soft Bake to Product Line
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity